nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.128	0.356	CbGbCtD
Desmopressin—PTGS2—Etoposide—peripheral nervous system neoplasm	0.126	0.349	CbGbCtD
Desmopressin—PTGS1—Etoposide—peripheral nervous system neoplasm	0.107	0.295	CbGbCtD
Desmopressin—AVPR2—Arf6 trafficking events—NME1—peripheral nervous system neoplasm	0.00715	0.0649	CbGpPWpGaD
Desmopressin—AVPR1B—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00359	0.0326	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00354	0.0322	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00321	0.0292	CbGpPWpGaD
Desmopressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—GNAS—peripheral nervous system neoplasm	0.00314	0.0286	CbGpPWpGaD
Desmopressin—AVPR2—Aquaporin-mediated transport—GNAS—peripheral nervous system neoplasm	0.00274	0.0249	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.0026	0.0236	CbGpPWpGaD
Desmopressin—AVPR1A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00249	0.0226	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00246	0.0223	CbGpPWpGaD
Desmopressin—AVPR2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00244	0.0221	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00238	0.0216	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00222	0.0202	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00181	0.0164	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00173	0.0158	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00165	0.015	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00164	0.0149	CbGpPWpGaD
Desmopressin—AVPR1B—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00161	0.0146	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00159	0.0145	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00148	0.0134	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00144	0.0131	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00135	0.0122	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00125	0.0114	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00125	0.0113	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0012	0.0109	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00119	0.0108	CbGpPWpGaD
Desmopressin—AVPR1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00112	0.0102	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.0011	0.01	CbGpPWpGaD
Desmopressin—AVPR2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.0011	0.00995	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00107	0.0097	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00102	0.00929	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000999	0.00908	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000929	0.00844	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000914	0.00831	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00089	0.00809	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00089	0.00808	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000876	0.00796	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000813	0.00739	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000775	0.00704	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00074	0.00672	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000735	0.00667	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000711	0.00646	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000709	0.00644	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000704	0.00639	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000704	0.00639	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000649	0.0059	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000644	0.00585	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000639	0.00581	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000625	0.00568	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000617	0.00561	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000613	0.00557	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000607	0.00552	CbGpPWpGaD
Desmopressin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000598	0.00543	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000564	0.00512	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00056	0.00508	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000549	0.00498	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000537	0.00488	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000533	0.00484	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000527	0.00479	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000526	0.00478	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000493	0.00448	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000489	0.00444	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000488	0.00443	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.000919	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000484	0.0044	CbGpPWpGaD
Desmopressin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000484	0.000915	CcSEcCtD
Desmopressin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000913	CcSEcCtD
Desmopressin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000482	0.000912	CcSEcCtD
Desmopressin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000911	CcSEcCtD
Desmopressin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000481	0.00091	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00048	0.000908	CcSEcCtD
Desmopressin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000478	0.000904	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000901	CcSEcCtD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000475	0.00431	CbGpPWpGaD
Desmopressin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000472	0.000893	CcSEcCtD
Desmopressin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.000892	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000471	0.00428	CbGpPWpGaD
Desmopressin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.000888	CcSEcCtD
Desmopressin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.000888	CcSEcCtD
Desmopressin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000469	0.000888	CcSEcCtD
Desmopressin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000468	0.000885	CcSEcCtD
Desmopressin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000467	0.000884	CcSEcCtD
Desmopressin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000465	0.000881	CcSEcCtD
Desmopressin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000465	0.000881	CcSEcCtD
Desmopressin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000464	0.000877	CcSEcCtD
Desmopressin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000877	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000461	0.000872	CcSEcCtD
Desmopressin—Infection—Etoposide—peripheral nervous system neoplasm	0.000461	0.000871	CcSEcCtD
Desmopressin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00087	CcSEcCtD
Desmopressin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00046	0.000869	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000459	0.00417	CbGpPWpGaD
Desmopressin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000459	0.000869	CcSEcCtD
Desmopressin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000864	CcSEcCtD
Desmopressin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000861	CcSEcCtD
Desmopressin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00086	CcSEcCtD
Desmopressin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000452	0.000856	CcSEcCtD
Desmopressin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000452	0.000856	CcSEcCtD
Desmopressin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000452	0.000856	CcSEcCtD
Desmopressin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000451	0.000853	CcSEcCtD
Desmopressin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00045	0.000852	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00045	0.00409	CbGpPWpGaD
Desmopressin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000448	0.000848	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000447	0.00406	CbGpPWpGaD
Desmopressin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000845	CcSEcCtD
Desmopressin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000842	CcSEcCtD
Desmopressin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000442	0.000836	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000833	CcSEcCtD
Desmopressin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00044	0.000832	CcSEcCtD
Desmopressin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000438	0.000829	CcSEcCtD
Desmopressin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000438	0.000828	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000437	0.000826	CcSEcCtD
Desmopressin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000433	0.000819	CcSEcCtD
Desmopressin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.000806	CcSEcCtD
Desmopressin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000805	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000803	CcSEcCtD
Desmopressin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.0008	CcSEcCtD
Desmopressin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000422	0.000798	CcSEcCtD
Desmopressin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00042	0.000795	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000417	0.00379	CbGpPWpGaD
Desmopressin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000417	0.000789	CcSEcCtD
Desmopressin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000416	0.000787	CcSEcCtD
Desmopressin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000787	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000416	0.00378	CbGpPWpGaD
Desmopressin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000413	0.000782	CcSEcCtD
Desmopressin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000412	0.00078	CcSEcCtD
Desmopressin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000411	0.000777	CcSEcCtD
Desmopressin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000407	0.00077	CcSEcCtD
Desmopressin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.000769	CcSEcCtD
Desmopressin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000404	0.000764	CcSEcCtD
Desmopressin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000403	0.000762	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000402	0.00365	CbGpPWpGaD
Desmopressin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0004	0.000757	CcSEcCtD
Desmopressin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0004	0.000757	CcSEcCtD
Desmopressin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0004	0.000756	CcSEcCtD
Desmopressin—Pain—Etoposide—peripheral nervous system neoplasm	0.000396	0.00075	CcSEcCtD
Desmopressin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000396	0.00075	CcSEcCtD
Desmopressin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000749	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000743	CcSEcCtD
Desmopressin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.000743	CcSEcCtD
Desmopressin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000392	0.000741	CcSEcCtD
Desmopressin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000739	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000385	0.0035	CbGpPWpGaD
Desmopressin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000728	CcSEcCtD
Desmopressin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000727	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000384	0.00349	CbGpPWpGaD
Desmopressin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000382	0.000723	CcSEcCtD
Desmopressin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00038	0.00072	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00038	0.00345	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000379	0.000717	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000379	0.00344	CbGpPWpGaD
Desmopressin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000378	0.000716	CcSEcCtD
Desmopressin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.000714	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000378	0.00343	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000377	0.00342	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000376	0.00342	CbGpPWpGaD
Desmopressin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000374	0.000708	CcSEcCtD
Desmopressin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000374	0.000708	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000373	0.00339	CbGpPWpGaD
Desmopressin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000373	0.000705	CcSEcCtD
Desmopressin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.000704	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000372	0.00338	CbGpPWpGaD
Desmopressin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000368	0.000697	CcSEcCtD
Desmopressin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000694	CcSEcCtD
Desmopressin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000366	0.000693	CcSEcCtD
Desmopressin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000366	0.000693	CcSEcCtD
Desmopressin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000693	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000365	0.00332	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000365	0.00331	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000365	0.00331	CbGpPWpGaD
Desmopressin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000364	0.000688	CcSEcCtD
Desmopressin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000363	0.000687	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000362	0.00329	CbGpPWpGaD
Desmopressin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000684	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000683	CcSEcCtD
Desmopressin—Rash—Vincristine—peripheral nervous system neoplasm	0.000361	0.000683	CcSEcCtD
Desmopressin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00036	0.000682	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000682	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00068	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000678	CcSEcCtD
Desmopressin—Headache—Vincristine—peripheral nervous system neoplasm	0.000358	0.000678	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000673	CcSEcCtD
Desmopressin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.000667	CcSEcCtD
Desmopressin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000667	CcSEcCtD
Desmopressin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000655	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000647	CcSEcCtD
Desmopressin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000342	0.000646	CcSEcCtD
Desmopressin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00034	0.000643	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000642	CcSEcCtD
Desmopressin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000642	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000642	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000335	0.00304	CbGpPWpGaD
Desmopressin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000632	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000631	CcSEcCtD
Desmopressin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000333	0.000629	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000629	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000628	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000628	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000625	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000624	CcSEcCtD
Desmopressin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000621	CcSEcCtD
Desmopressin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000328	0.00062	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000617	CcSEcCtD
Desmopressin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000609	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000606	CcSEcCtD
Desmopressin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000319	0.000604	CcSEcCtD
Desmopressin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000319	0.000603	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000318	0.00289	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000318	0.00289	CbGpPWpGaD
Desmopressin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000602	CcSEcCtD
Desmopressin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000602	CcSEcCtD
Desmopressin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000317	0.0006	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000598	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000316	0.00287	CbGpPWpGaD
Desmopressin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000594	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000594	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000594	CcSEcCtD
Desmopressin—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000313	0.00284	CbGpPWpGaD
Desmopressin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000591	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000312	0.00283	CbGpPWpGaD
Desmopressin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000585	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000581	CcSEcCtD
Desmopressin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000307	0.00058	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000306	0.00278	CbGpPWpGaD
Desmopressin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000579	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000578	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000577	CcSEcCtD
Desmopressin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000574	CcSEcCtD
Desmopressin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000569	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000561	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000559	CcSEcCtD
Desmopressin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000295	0.000558	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000557	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000557	CcSEcCtD
Desmopressin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000554	CcSEcCtD
Desmopressin—Rash—Etoposide—peripheral nervous system neoplasm	0.000292	0.000553	CcSEcCtD
Desmopressin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000292	0.000552	CcSEcCtD
Desmopressin—Headache—Etoposide—peripheral nervous system neoplasm	0.00029	0.000549	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000549	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000289	0.00263	CbGpPWpGaD
Desmopressin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000547	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000288	0.00262	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000288	0.00262	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000287	0.00261	CbGpPWpGaD
Desmopressin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000543	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000541	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000286	0.0026	CbGpPWpGaD
Desmopressin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000541	CcSEcCtD
Desmopressin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00054	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000284	0.00258	CbGpPWpGaD
Desmopressin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000536	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000532	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000529	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000279	0.00254	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000279	0.00253	CbGpPWpGaD
Desmopressin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000526	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000277	0.00251	CbGpPWpGaD
Desmopressin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000522	CcSEcCtD
Desmopressin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000275	0.000521	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00052	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000517	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000513	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000513	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000512	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000511	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000509	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000507	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000267	0.00243	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000266	0.00242	CbGpPWpGaD
Desmopressin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000503	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000501	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.0005	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000264	0.0024	CbGpPWpGaD
Desmopressin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000496	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000493	CcSEcCtD
Desmopressin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000492	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000492	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00049	CcSEcCtD
Desmopressin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000488	CcSEcCtD
Desmopressin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000486	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000256	0.00232	CbGpPWpGaD
Desmopressin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000484	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000483	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000482	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000481	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00048	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000254	0.0023	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000253	0.0023	CbGpPWpGaD
Desmopressin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000477	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000252	0.00228	CbGpPWpGaD
Desmopressin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000475	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000251	0.00228	CbGpPWpGaD
Desmopressin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000474	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000474	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000473	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000471	CcSEcCtD
Desmopressin—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000248	0.00226	CbGpPWpGaD
Desmopressin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000469	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000469	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000246	0.00224	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000245	0.00222	CbGpPWpGaD
Desmopressin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000459	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000455	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000455	CcSEcCtD
Desmopressin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000452	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000448	CcSEcCtD
Desmopressin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000447	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000446	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000445	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000235	0.00213	CbGpPWpGaD
Desmopressin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000444	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000442	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000441	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00044	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000438	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000437	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000434	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000433	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000427	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000424	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000424	CcSEcCtD
Desmopressin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00042	CcSEcCtD
Desmopressin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00042	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000414	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000411	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000408	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000216	0.00196	CbGpPWpGaD
Desmopressin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000406	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000405	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000404	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000402	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.0004	CcSEcCtD
Desmopressin—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000211	0.00192	CbGpPWpGaD
Desmopressin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000395	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000393	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000392	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000207	0.00188	CbGpPWpGaD
Desmopressin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000391	CcSEcCtD
Desmopressin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000389	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000389	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000389	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000389	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.0002	0.00181	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000198	0.0018	CbGpPWpGaD
Desmopressin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000375	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000372	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000192	0.00175	CbGpPWpGaD
Desmopressin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000362	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000361	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00036	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00036	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000188	0.00171	CbGpPWpGaD
Desmopressin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000353	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000348	CcSEcCtD
Desmopressin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000336	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000335	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000176	0.0016	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000176	0.0016	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000174	0.00159	CbGpPWpGaD
Desmopressin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000326	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000325	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000171	0.00155	CbGpPWpGaD
Desmopressin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000322	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00017	0.00154	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000168	0.00152	CbGpPWpGaD
Desmopressin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000313	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000311	CcSEcCtD
Desmopressin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00031	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00031	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000163	0.00148	CbGpPWpGaD
Desmopressin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000308	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000162	0.00147	CbGpPWpGaD
Desmopressin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000301	CcSEcCtD
Desmopressin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000292	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000289	CcSEcCtD
Desmopressin—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	0.000153	0.00139	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000152	0.00139	CbGpPWpGaD
Desmopressin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000287	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000287	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000151	0.00137	CbGpPWpGaD
Desmopressin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000285	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00015	0.00136	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000149	0.00136	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000148	0.00135	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000147	0.00133	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	0.000147	0.00133	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GNS—peripheral nervous system neoplasm	0.000145	0.00132	CbGpPWpGaD
Desmopressin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00027	CcSEcCtD
Desmopressin—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	0.000141	0.00128	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000141	0.00128	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000139	0.00127	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000128	0.00116	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	0.000121	0.0011	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.00012	0.00109	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000118	0.00108	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	0.000116	0.00106	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	0.000112	0.00102	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000112	0.00101	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000108	0.000985	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000107	0.000976	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000106	0.00096	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000105	0.000953	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000104	0.000943	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000103	0.000936	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000101	0.00092	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.98e-05	0.000906	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.85e-05	0.000895	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	9.26e-05	0.000841	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.01e-05	0.000818	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	8.78e-05	0.000797	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.39e-05	0.000762	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.21e-05	0.000745	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.19e-05	0.000744	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.15e-05	0.00074	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	7.82e-05	0.000711	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.73e-05	0.000702	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.68e-05	0.000697	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.52e-05	0.000683	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.46e-05	0.000678	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.46e-05	0.000678	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.45e-05	0.000677	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.39e-05	0.000672	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	7.36e-05	0.000668	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	7.35e-05	0.000668	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	7.07e-05	0.000643	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.92e-05	0.000629	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.89e-05	0.000626	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.83e-05	0.00062	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.78e-05	0.000616	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.59e-05	0.000599	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.24e-05	0.000567	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	6.21e-05	0.000564	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.2e-05	0.000563	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	6e-05	0.000545	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.92e-05	0.000538	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.89e-05	0.000535	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	5.84e-05	0.00053	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.82e-05	0.000529	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.81e-05	0.000528	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.77e-05	0.000524	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.78e-05	0.000434	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	4.77e-05	0.000433	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.74e-05	0.000431	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.68e-05	0.000425	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.57e-05	0.000415	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.53e-05	0.000412	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.03e-05	0.000366	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4e-05	0.000364	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	3.96e-05	0.000359	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	3.13e-05	0.000284	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	2.38e-05	0.000216	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—peripheral nervous system neoplasm	2.22e-05	0.000201	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.74e-05	0.000158	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000147	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	1.54e-05	0.00014	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000117	CbGpPWpGaD
